Iovance Biotherapeutics, Inc. demonstrates improved Q4 results, with $87M revenue and a 50% gross margin. Learn more about IOVA stock here.
Q2 2026 Earnings Call February 24, 2026 3:30 PM ESTCompany ParticipantsMike Roan - Chief Executive OfficerMandy Simpson ...
CPD accredited public sector news, comment & analysis for Civil Servants responsible for building, shaping and delivering transformational public services. The UK's No1 Public Sector Magazine.
The new tool is designed to help government and enterprise network defenders analyse tens of millions of malware samples at ...